Recommendation
- https://pubmed.ncbi.nlm.nih.gov/36330672/PubMedDostarlimab for recurrent mismatch repair-deficient endometrial ...Although the agent is substantially more costly, dostarlimab became cost-effective when its cost was reduced to $5489 per cycle. Keywords: cost-effectiveness; ...
- https://en.wikipedia.org/wiki/DostarlimabDostarlimab - WikipediaDostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer.
- https://everyone.org/jemperli-dostarlimabBuy Jemperli (dostarlimab) Online • Price & Costs | Everyone.orgJemperli (dostarlimab) is a programmed death receptor-1 (PD-1)-blocking antibody, for use in: It is available in vial form for intravenous infusion, containing ...
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9289427/PubMed Central (PMC)Dostarlimab, a boon or a healthcare burden- too early to acertain ...The cost of each dose of the drug is $11,000 (Rs. 8,54,119/-) € 19355 (Rs 16,07,316/-) and Rs. 3.4 lakh/vial in India. Is this amount affordable by all members ...
- https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.17338Obstetrics and GynecologyDostarlimab for recurrent mismatch repair‐deficient endometrial ...Nov 4, 2022 ... In one-way sensitivity analyses, dostarlimab was cost-effective when its cost was reduced to $4905 (52% reduction). These results were robust in ...
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1391896/fullCost-effectiveness of dostarlimab plus chemotherapy for ... - FrontiersJun 20, 2024 ... Dostarlimab in combination with chemotherapy was cost-effective for primary advanced or recurrent dMMR EC from the perspective of a United States payer.
- https://www.ndtv.com/science/10-points-on-dostarlimab-the-drug-that-cured-cancer-during-trials-3049609NDTV.com10 Points On Dostarlimab, The Drug That 'Cured' Cancer During TrialsJun 8, 2022 ... ... Dostarlimab costs nearly ₹ 8.55 lakh per dose. (Representational). A study has found that a drug named Dostarlimab has helped treat rectal ...
- https://www.ncbi.nlm.nih.gov/books/NBK604823/NCBI BookshelfDostarlimab (Jemperli) - NCBI BookshelfAccording to the clinical experts we consulted, patients with primary advanced or recurrent dMMR or MSI-H endometrial cancer experience poor response rates to ...
- https://ijgc.bmj.com/content/31/Suppl_4/A16.1OP013/#417 Cost-effectiveness of dostarlimab in advanced ...Dostarlimab is associated with greater survival compared with other treatments for women with recurrent dMMR endometrial cancer. However, the agent is ...
- https://www.medscape.com/viewarticle/995014MedscapeFDA OKs Dostarlimab Plus Chemo for Endometrial CancerJul 31, 2023 ... Drugs.com lists dostarlimab's price at $11,712.66 for 500 mg/10 mL intravenous solution. M. Alexander Otto is a physician assistant with a ...
Recommend
All Categories
Others
Privacy Policy
Terms of Use
We scour the internet for answers to just about everything - from finding the latest kitchenware to finding
the best travel destinations.
A unique Q&A structure provides you with relevant information in a quick-read, easy-to-use format. With the
most common questions answered in this format, you're sure to find what you're looking for.
Copyright © 2024 Seahia. All rights reserved